Form C - Offering Statement:
SEC Accession No. 0001670254-21-000639
Filing Date
2021-05-05
Accepted
2021-05-04 20:12:06
Documents
13

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 11762
2 document_1.pdf EX-99 7327921
3 document_2.pdf EX-99 2141695
4 document_3.pdf EX-99 19252025
5 document_4.pdf EX-99 19252025
6 document_5.pdf EX-99 9302341
7 document_6.pdf EX-99 9302255
8 document_7.pdf EX-99 10892744
9 document_8.pdf EX-99 822417
10 document_9.pdf EX-99 3829629
11 document_10.pdf EX-99 524358
12 document_11.pdf EX-99 877730
13 documents_list.htm EX-99 123
  Complete submission text file 0001670254-21-000639.txt   113098452
Mailing Address 2145 S CLERMONT ST STE 3 DENVER CO 80222
Business Address 2145 S CLERMONT ST STE 3 DENVER CO 80222 5106982462
Canine Life Sciences Inc. (Filer) CIK: 0001857342 (see all company filings)

EIN.: 844068759
Type: C | Act: 33 | File No.: 020-28031 | Film No.: 21890677